| Michael Sidney Horowitz, MD | |
|
112 Bloomfield Ave, Caldwell, NJ 07006-5336 | |
| (973) 364-1444 | |
| (973) 364-0101 |
| Full Name | Michael Sidney Horowitz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 112 Bloomfield Ave, Caldwell, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275647174 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA02866900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Sidney Horowitz, MD 112 Bloomfield Ave, Caldwell, NJ 07006-5336 Ph: (973) 364-1444 | Michael Sidney Horowitz, MD 112 Bloomfield Ave, Caldwell, NJ 07006-5336 Ph: (973) 364-1444 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
According to new visual perception research from a team at Boston University, the use of boldly colored tableware is a mealtime aid to those with severe AD, helping individuals overcome a diminished sensitivity to visual contrast, a condition often found among people with advanced AD.
The need to understand how and why such spread occurs is vital to containing it. A new medRxiv* preprint describes a significant reduction in transmission during the summer (by 42%), which is comparable to the impact of the most effective non-pharmaceutical intervention (NPI).
Researchers in the United States and Canada have described the structural basis and mode of action for two monoclonal antibodies that potently neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
Giovanni Campanile, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Smull Ave, Caldwell, NJ 07006 Phone: 862-260-3188 Fax: 973-401-2489 | |
Dr. Albert Siu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 526 Bloomfield Ave, Suite 104, Caldwell, NJ 07006 Phone: 973-226-0500 Fax: 973-226-7221 | |
Dr. Stanley Mayrowetz, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 8 Brookside Ave, Caldwell, NJ 07006 Phone: 973-228-3333 Fax: 973-228-9023 | |
Dr. Joel Notkin, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 526 Bloomfield Ave, Caldwell, NJ 07006 Phone: 973-226-0500 Fax: 973-226-7221 | |
Dr. Lynette G Suarez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 360 Bloomfield Ave, Caldwell, NJ 07006 Phone: 973-226-8464 Fax: 973-226-3750 | |
Edwin Suarez, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 360 Bloomfield Ave, Caldwell, NJ 07006 Phone: 973-226-0722 Fax: 973-226-3750 |